...
首页> 外文期刊>Lupus >Lupus nephritis in Croatian children: clinicopathologic findings and outcome
【24h】

Lupus nephritis in Croatian children: clinicopathologic findings and outcome

机译:克罗地亚儿童狼疮性肾炎的临床病理发现和结局

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We report clinical and histopathological features, treatment and outcome of 37 Croatian children with biopsy-proven lupus nephritis seen over a 30-year period. The mean age at lupus nephritis presentation was 12.11 +/- 2.59 years (range 4.66-17.0). The most frequent histopathological finding was class IV (37.8%), followed by class III (35.1%), class V (16.2 %) and class II (10.8 %) lupus nephritis. Compared with other classes there were more boys among patients with class IV lupus nephritis, and hypertension, nephrotic syndrome and decreased estimated glomerular filtration rate at presentation were more common. The median histopathological activity and total scores were highest in class IV lupus nephritis patients. The mean follow-up was 7.14 +/- 4.71 years, ranging from 1.1 years to 21.0 years. Kaplan-Meier estimates of patient and kidney (without renal failure) survival rates were 90.5% and 87 % at five years. The renal survival rate of class IV lupus nephritis patients was found significantly lower compared with other histological classes combined. Decreased estimated glomerular filtration rate at the time of diagnosis, class IV lupus nephritis versus other lupus nephritis classes, and high total histological score were the parameters significantly associated with adverse outcome. The therapy with cyclophosphamide showed as superior to the therapy with azathioprine.
机译:我们报告了37例经活检证实为狼疮性肾炎的克罗地亚儿童在30年中的临床和组织病理学特征,治疗和结局。狼疮性肾炎表现的平均年龄为12.11 +/- 2.59岁(范围4.66-17.0)。最常见的组织病理学发现是IV级(37.8%),其次是III级(35.1%),V级(16.2%)和II级(10.8%)狼疮性肾炎。与其他班级相比,IV级狼疮性肾炎患者中男孩较多,出现时高血压,肾病综合征和估计的肾小球滤过率降低更为常见。 IV级狼疮性肾炎患者的中位组织病理学活动和总分最高。平均随访时间为7.14 +/- 4.71年,范围为1.1年至21.0年。 Kaplan-Meier估计患者和肾脏(无肾衰竭)的五年生存率分别为90.5%和87%。发现IV级狼疮性肾炎患者的肾脏存活率明显低于其他组织学类别的总和。诊断时估计的肾小球滤过率降低,IV级狼疮性肾炎与其他狼疮性肾炎的分类以及较高的总组织学评分是与不良预后显着相关的参数。环磷酰胺治疗优于硫唑嘌呤治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号